Chimerix Inc

NASDAQ:CMRX 4:00:00 PM EDT

1.22

-0.03 (-2.40%)

: $1.22 0.00 (0.00%)

Products

Chimerix Announces FDA Acceptance Of New Drug Application For Brincidofovir As A Medical Countermeasure For Smallpox

Published: 12/07/2020 12:26 GMT

CMRX

Chimerix Inc (CMRX) - Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir As a Medical Countermeasure for Smallpox.
Chimerix Inc - FDA Granted Priority Review and Set Action Date of April 7, 2021 Under PDUFA.